Aclaris Therapeutics (ACRS)'s 30-day implied volatility (IV30) was 116.7% at the close on October 21, 2026, down from 136.7% the day before, against a 52-week range of 49.6% to 148.4%. Its 20-day historical volatility was 103.9%.
Data as of October 21, 2026.